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Abstract
Background: Clinical decision support (CDS) for electronic prescribing systems (computerized physician order
entry) should help prescribers in the safe and rational use of medicines. However, the best ways to alert users to
unsafe or irrational prescribing are uncertain. Specifically, CDS systems may generate too many alerts, producing
unwelcome distractions for prescribers, or too few alerts running the risk of overlooking possible harms. Obtaining
the right balance of alerting to adequately improve patient safety should be a priority.
Methods: A workshop funded through the European Regional Development Fund was convened by the University
Hospitals Birmingham NHS Foundation Trust to assess current knowledge on alerts in CDS and to reach a
consensus on a future research agenda on this topic. Leading European researchers in CDS and alerts in electronic
prescribing systems were invited to the workshop.
Results: We identified important knowledge gaps and suggest research priorities including (1) the need to
determine the optimal sensitivity and specificity of alerts; (2) whether adaptation to the environment or
characteristics of the user may improve alerts; and (3) whether modifying the timing and number of alerts will lead
to improvements. We have also discussed the challenges and benefits of using naturalistic or experimental studies
in the evaluation of alerts and suggested appropriate outcome measures.
Conclusions: We have identified critical problems in CDS, which should help to guide priorities in research to
evaluate alerts. It is hoped that this will spark the next generation of novel research from which practical steps can
be taken to implement changes to CDS systems that will ultimately reduce alert fatigue and improve the design of
future systems.
Keywords: Clinical Decision Support Systems, Medical Order Entry Systems
Background
Computerized physician order entry and clinical decision
support
Computerized physician (or provider) order entry (CPOE)
systems allow users to prescribe using a computer system,
reducing the risk of prescribing errors resulting from il-
legible handwriting or transcription errors. They have
also been shown to reduce medication errors and adverse
drug reactions in hospitals [1-6], although large multi-
centred trials, which give ‘guidance in optimizing CPOE
implementations’ are lacking [7]. CPOE systems can have
integrated clinical decision support (CDS), which attempts
to improve clinicians’ decisions through guidance, alerts,
and reminders. These CDS systems draw on information
contained in supporting knowledge database(s), which
are often integrated with software algorithms that gen-
erate alerts during drug prescribing [8,9] and may also
address issues relevant for the administration process
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alerts in identifying and preventing erroneous or less
optimal prescribing [11-14].
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to alert prescribers correctly when patients are at risk of
experiencing drug-induced harm, for example, from a
drug–drug interaction or drug allergy. The specificity of
the CDS system is a measure of its ability to distinguish
between events that put an individual at risk of harm
and non-events that will not: the more false positives,
the lower the specificity. Previous research has led to
the suggestion that safe alerting systems should have
high specificity and sensitivity, present clear informa-
tion, not unnecessarily disrupt workflow, and facilitate
safe and efficient handling of alerts [15]. Indeed, the
ideal alert should demonstrate the following character-
istics: provision of the right (correct) information, to
the right person, in the right CDS intervention format,
through the right channel, and at the right time in the
w o r k f l o w[ 1 6 ] .T h e s e' f i v er i g h t s 'm a yb eb e t t e ra c h i e v e d
when alerts are tailored and filtered to take into account
the characteristics of (1) the organizational unit and the
user, (2) the patient or case, and (3) the alert [17].
Knowledge of alert fatigue in CDS systems
CDS alerts have the potential to cause harm to patients by
occurring too frequently and thus producing distracting
‘noise’ in the system [11-14]. In most, if not all, systems a
large proportion of alerts generated by CDS is overridden
(i.e. clinician chooses to proceed without adjusting or can-
celling the prescription) [10,15,18,19]. This may be a
symptom of ‘alert fatigue’, the mental state resulting from
alerts consuming too much time and mental energy,
which may increase the chance that future alerts pertinent
to patient safety will be overridden [20-22] along with clin-
ically irrelevant ones [23]. In general terms, exposure to
frequent false alarms can desensitize users so that they
ignore and increasingly mistrust alarms [24].
Most of the focus on reducing override rates in CDS
systems considers strategies such as the customization
of third party providers’ sets of alerts [25-28], imple-
mentation of highly specific algorithms [18], and use of
tiered severity grading to stratify and reduce the number
of interruptive alerts [29,30]. Other suggested strategies to
counteract alert fatigue have included turning off fre-
quently overridden alerts and directing time-dependent
drug–drug interaction alerts to nurses [31,32]. A formal
framework to evaluate the appropriateness of alerts may
also prove useful [33].
Alert fatigue continues to plague and frustrate users
despite varying improvement strategies [34] and the
overall effect and generalizability of such strategies on
patient safety is unclear. Indeed, in many European
countries, hospital electronic prescribing systems are in
the embryonic stages, and vary widely in terms of their
use and how they are being both developed and
implemented. Therefore, the need for further research
in the use of alerts in CDS systems remains. To address
these issues, European experts on CDS attended a work-
shop in Birmingham, United Kingdom. Here, we describe
the agreed consensus from the workshop on the current
gaps in the research, the challenges of improving alerting
in CDS systems, and the issues that were as yet un-
answered. Recommendations are also provided for the
strategic direction of future research on CDS-based safety
alerts from a European perspective.
Methods
Researchers with a strong publication record in the field
of CDS were identified through literature searches and
were invited by email to attend a two-day workshop in
Birmingham, United Kingdom, in November 2011 on
“building research capacity in the study of alerts in CDS
systems”. The workshop was funded by the European
Regional Development Fund and organized by the Univer-
sity Hospitals Birmingham NHS Foundation Trust. No
ethical approval was required for this work. The objectives
of the workshop were (1) to identify key knowledge gaps
in the study of CDS-based alerting; (2) to identify research
priorities on CDS-based alerting; and (3) to identify re-
search methodologies to evaluate alerts.
Workshop participants (see online Additional file 1)
separated into smaller groups for directed discussions
after a general discussion of previous work on the nature
of alert fatigue in CPOE and in other industries. Re-
search questions to answer the objectives were discussed
in each smaller participants group (N=4–6 participants)
first, and then summarized in the plenum. All partici-
pants provided full consent for the recording of discus-
sions. Minutes from the discussions were transcribed
and circulated among the group for approval following
the workshop. The main themes highlighted and
discussed at the workshop were abstracted, and further
sub-themes identified. All participants were requested to
comment on various iterative drafts and their comments
are incorporated into this paper. The following report
reflects the discussions and recommendations of the
expert participants, with additional contributions from
an invitee who was unable to attend.
Results
Knowledge gaps in the study of alerts in CDS systems
The workshop participants identified knowledge gaps in
the study of alerts in CDS systems that require further
investigation (Table 1).
Important research priorities
The following four priorities for research on alerts in
CDS systems have been developed from the gaps in
knowledge identified in Table 1. As time was limited, the
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where gaps in knowledge were identified.
Determine the optimum sensitivity and specificity of a CDS
system in practice
We agreed that the perfect CDS system would be both
100% sensitive and 100% specific. Indeed clinicians will
wish the overall sensitivity and specificity to be high; that
is, will wish to know all those patients who will in fact ex-
perience drug-induced harm, and none of those who will
suffer no harm (whether or not they are at risk). Current
systems tend to have high sensitivity but often the specifi-
city is low [38]. Sensitivities below 100% are risky and may
contribute to patient harm, especially for the most injuri-
ous events. If we strive for high sensitivity, we will inevit-
ably increase the number of alerts. Should we instead be
looking for better specificity?
It is important that the system is able to draw in add-
itional information from beyond the knowledge base – by
which we mean the collection of evidence-based informa-
tion about drugs and their interactions – to increase speci-
ficity, for example through the integration of individual
patient information such as laboratory values and co-
morbidities with information on medicines [39-42]. The
challenge is in ensuring that drug information is accurate,
comprehensive and up-to-date, whilst keeping the process
manageable in terms of expertise, time, and resources. One
solution may be the collaborative development and sharing
of knowledge bases between countries [9,43]. Indeed, na-
tional knowledge bases exist, such as the Dutch national
drug database (G-Standaard), which serves as a professional
standard for pharmacists in the Netherlands, and is the
standard from which all Dutch CPOE systems are based
[44]. Sharing of such knowledge bases may enable the
effective use of resources and harnessing of expertise.
However, recent findings suggest that systems can be
both sensitive and specific, or indeed lack both qualities
[45]. Furthermore, system quality may differ with regards
to different alert categories (e.g. overdose vs. drug–drug
interactions), and differences when alerting for medica-
tions only, as opposed to a combination of medication and
patient parameters [45,46]. Future studies involving rigor-
ous testing, alongside more in-depth analysis of system
design features leading to high sensitivity and specificity,
can be used to guide future CPOE system designs in order
to determine the optimum sensitivity and specificity in
the real world. By comparing differences in the design
of current systems, it may be possible to identify a gold
s t a n d a r do nw h i c ht ob a s ef u t u r eC P O Es y s t e m s .
Research from other industries may help guide discus-
sions on the appropriate balance between specificity and
sensitivity. A meta-analysis identified experimental studies
that compared human performance aided by imperfect
diagnostic automation with unaided human performance
detecting the same signals — when sensitivity of auto-
mated alerts fell below 70%, performance was worse than
in the absence of automation [47]. This is a rough estimate
(95% confidence interval = 56–84%), but it suggests that
automated systems require the sensitivity of alerts to be
over some minimum value if they are to be beneficial.
Indeed, this apparently counter-intuitive finding that poor
CDS is worse than no CDS emphasizes the dangers of
systems that miss important signals.
Determine whether personalization of alerts will reduce
alert fatigue
Certainly, the importance of applying human factors princi-
ples to matters such as placement, visibility, prioritization,
and colour in the design of CDS alerts is well established
[48-50]. Customization to the setting in which the system is
used (the ‘use environment’) could provide an opportunity
to eliminate inappropriate alerts and requires further evalu-
ation. For example, an interaction warning for excessive
Table 1 Identified knowledge gaps in the research on CDS alerts
Research gap Comments
1. Sensitivity and specificity of a CDS system It is unclear whether there is an ideal sensitivity and specificity of a CDS system or whether there is an
optimum number of alerts within a system.
2. Presentation and personalization of alerts The best strategies for contextualizing, presenting and filtering alerts for users are still uncertain.
3. Timing of alerts The appropriate point in the workflow process for alerting users needs to be determined.
4. Relevance of the outcome measures in
the study of alerts
Studies on effects of alerts often include surrogate markers instead of patient parameters as outcome
measures.
5. Measurement of the quality of alerts The criteria by which the quality of an alert is judged or whether an alert adds value to a system have
not been defined.
6. Design and firing of alerts/rules A systematic approach to the generation of alerts has never been explicitly described.
7. Legal issues The legal implications in the study of alert fatigue are yet to be established. This has been, however,
discussed in an American context [35], with particular emphasis on the liability implications of CDS with
drug–drug interactions [36,37].
8. Human factors and usability More investigation of the interaction between users and CDS systems is needed.
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meaningless in anaesthetized patients. Hence, such alerts
would be suppressed in the “operating theatre” but not in
“general practice”.
Allowing individual users to personalize the interface
design of CDS alerts may also reduce alert fatigue. Indeed,
CDS system developers can learn a lot from smartphones,
which allow for the personalization of their user interface
(e.g. alter icon arrangement, font size, or background
colour). Most smartphone users enjoy the ability to modify
their devices in certain ways. Conversely, we agreed that
CDS alerts are often boring, difficult to see and under-
stand, and thus frustrating to users. In addition, we
discussed that CDS alerts often result in negative feeling
in users, for example, because their clinical decision mak-
ing has been criticized. Determining whether cosmetic
personalization improves usability and receptivity of CDS
alerts is important and should be investigated.
Personalization of alerts may not just be limited to the
user interface, but may be done in an automatic way
based upon a user’s familiarity with certain risk situa-
tions, training, and expertise. For example, frequent
users may require fewer alerts than those who rarely use
a system or a specific medicine. The development of
individualized alerts will require structured and system-
atic design to ensure that they are generated appropri-
ately for each patient. Allowing an individual prescriber
to have control over which alerts are switched on or off
may have some benefit, but could introduce the poten-
tial for error due to slips or lapses [51], particularly
when a clinician is busy or distracted. Determining
whether personalization in this way improves usability
and receptivity of CDS alerts is important.
Alerts are only valuable if they may change the patient’s
clinical management. Those that are irrelevant to clinical
management add to the alert burden without any clinical
benefit. Studies to identify and refine management deci-
sion support will be important.
Determine whether appropriate timing of an alert within
the prescribing process will reduce alert fatigue
We agreed that ideally alerts should be displayed as early
as possible in the prescribing process, and if possible, there
should be no more than one alert for any prescription (by
which we mean, an order for a single item). So, for ex-
ample, if a situation exists that would strictly contraindi-
cate a prescription (such as a clinically relevant allergy
alert) users should be alerted before they have gone too far
down the prescribing path. However, there are difficulties
in a system set up to show only one alert for one drug
prescription. For example, the user may have to enter
all necessary information (e.g. dose, route, frequency
and duration) before an overarching CDS alert relevant
to all elements of the prescription is shown. Alerting the
user as early as possible and having complete information
that can be integrated into a single CDS alert are not easily
compatible. We discussed a hierarchy of agreed alerts, that
is, a grading such as (i) prescribing absolutely contraindi-
cated; (ii) prescribe but only if certain conditions are met;
and (iii) prescribe where benefit outweighs harm. Such
a hierarchy would mitigate this conflict, since an alert at
the highest level that interrupted the process could be
displayed as soon as it was first encountered. However,
this may be difficult to achieve in practice. Indeed, de-
pending on the user interface of the computerized system,
one alert per item may not be practicable. For example,
when prescriptions for multiple drug items can be entered
all together it could be difficult to determine which alert
should be selected with priority. New research should
focus on assessing the impact of the timing and number
of alerts generated during one drug prescription.
Determine the relevance of the outcome measures in
evaluating alerts
One of the main challenges in designing and evaluating
alerts is deciding on what outcome measure(s) should be
used. Here we suggest potential measures (Table 2).
Table 2 Potential outcome measures for the evaluation of alerts in CDS
Suggested outcome measure Comments
Patient harm This entails identifying patient harms specific to the prescribing process that may be prevented by CDS; and then
establishing their relative importance.
Length of stay in hospital This measure has the benefit of being easily measured, but depends on several factors other than the quality of
prescribing.
Mortality Again, this measure has the benefit of being easily measured, but depends on several factors other than the
quality of prescribing.
Quality measures The National Quality Forum in the USA has developed quality measurements and test cases in order to capture
medical decision making and a direct link between decision process and quality of care [52].
Measures of clinical improvement Some examples include decreased fever and falling white cell count.
Medication errors [53] It is difficult to identify and often to define actual medication errors and perhaps even more challenging to
establish the potential harm caused by these errors.
Costs These may be an appropriate outcome measure, but the workshop’s view was that the primary aim of CDS is to
minimize harm, not cost.
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are obviously relevant such as mortality, are unlikely, be-
cause of their rarity, to give a full or reliable picture of
the value of alerts; and those which are more common
are less obviously relevant. The correct balance needs to
be established. There is also a need for consistent defini-
tions of medication error and therapeutic harm [53] in
order to increase the comparability of studies [54].
Research methods to evaluate alerts
The appropriate research methods for evaluating alerts
depend on the research question being asked. Here we
consider methods that would be of potential use in
evaluating alerts in CDS and for addressing the priorities
for research identified during the workshop.
Expert opinion
Expert opinion has been previously used to try to evalu-
ate alerts and potentially improve the quality of alerting.
For example, groups of clinicians have been asked to
agree on which alerts could be turned off safely within a
hospital system [32] and to assess the value of alerts for
120 drug–drug interactions [55]. This method has also
been used to identify and refine high-severity drug–drug
interactions [56] and to identify low-priority drug–drug
interactions that do not require interruptive alerts [57].
These studies may provide information on some re-
search gaps, such as determining which outcome is most
relevant to the specific research question. An expert
panel could be used to examine a large number of pre-
scriptions and see what warnings appear. The panel
would select an outcome measure and explore how to
reduce the number of warnings, in order to design more
specific alert algorithms. A possible increase in alert
adherence could then be investigated.
Observational (naturalistic) studies
Naturalistic studies involve the careful observation and
recording of behaviours and events in their natural
setting and they can be very powerful when based on
strong theoretical foundations. Such studies have an im-
portant role in the study of alerts in CDS systems and
previously have been used to explore factors affecting
prescribing errors in hospitals [58]. A possibility for a
naturalistic study would be to implement CDS systems
in one geographical area or electronic health record sys-
tem and study the outcome compared with other areas
or groups where no system exists. Alternatively, an
evaluation of the outcomes pre- and post-introduction
o faC D Ss y s t e mi no n es e t t i n gm a yp r o v i d eu s e f u li n -
formation on the effect of CDS alerts. Indeed, a recent
controlled trial demonstrated a reduction in the preva-
lence of potentially dangerous drug–drug interactions,
after implementation of a drug–drug interaction database
[59]. However, a given CDS system may produce different
responses in different healthcare settings [60].
Experimental studies
Experimental studies can allow for the manipulation and
testing of CDS alerts in a controlled environment. For
example, it would be possible to turn alerts on and off to
see the effect on override rates. This could be undertaken
in a safe setting that would not have any direct impact on
patient care or safety during the experiment. A previous
study found that the rates of prescribing errors fell signifi-
cantly when junior doctors were shown a modal alert – an
alert that requires users to interact with it before they can
return to the main interface – compared with a non-
modal alert [61]. There are few similar studies. They may
be the most practicable way to investigate the ideal level of
sensitivity and specificity, as well as determining the ef-
fects of the personalization of alerts for the user. However,
they may not take into account the effect of stressful
working environments on the user.
Comparing naturalistic and experimental study designs
Naturalistic studies have the advantage of providing a
real-life assessment of alerts and alert overrides. How-
ever, removing alerts and monitoring the effect may be
problematic and unethical. The effectiveness of such
studies is also dependent on having a suitable audit trail
and capturing the data reproducibly. Conversely, experi-
mental studies benefit from a controlled environment
with no ethical constraints. However, such studies may
not reflect real-life use of alerts accurately, as prescribers
could alter their use of a CPOE system when they are
being watched.
Challenges to implementing research methods
The value of the alert must in part be judged by the ac-
tions taken in response to it. This may, however, prove
challenging. There is, at present, no easy way to differen-
tiate between an informed decision to override an alert
and one that is ignored or missed, although this is a crit-
ical distinction. Some systems require a reason for over-
riding certain alerts – but this adds to the burden on the
end user, and only provides reliable feedback to the
system developers if the user provides the true reason
for overriding.
Both naturalistic and experimental approaches are valu-
able, but the sequencing of events within the study design
is important: the effectiveness of a naturalistic approach
depends on having a suitable audit trail and capturing the
data reproducibly. Randomization and masking in experi-
mental studies can be difficult in such circumstances [62].
There are also problems with screen capture designs, since
in naturalistic settings there are many actions to capture
successfully.
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that are looking to implement CPOE/CDS and monitor
the steps to full implementation. Nonetheless, the chal-
lenge of how to measure the adverse outcomes prevented
or caused by a decision support system remains, and a
gold standard defined by an expert group is needed to
achieve such measurement. This standard could then be
used as a yardstick to judge the system. However, this may
only test the system and not the outcome.
An ‘ideal’ design for studies of alerts in CDS systems
may not exist. One of the approaches could be a purpose-
ful synthesis/integration of different studies leading to new
insights. However, one specific study design may provide
considerable insight into CDS alerts. This would be to set
up a safe environment where alerts that are always over-
ridden are removed from a CDS system. After the alerts
are removed, the system is then interrogated to see what
happens in terms of override rates and potential patient
outcomes. If supported by an expert panel who could
assess existing alerts and select those for removal, an itera-
tive prospective study may be valuable.
Discussion
Summary of findings
We have identified several research priorities including
(1) the need to determine the optimal sensitivity and
specificity of alerts; (2) whether adaptation to the envir-
onment or characteristics of the user may improve
alerts; and (3) whether modifying the timing and num-
ber of alerts improves alerts. We have also discussed the
challenges and benefits of using naturalistic or experi-
mental studies in the evaluation of alerts and suggested
appropriate outcome measures.
We recommend that the reduction of alert fatigue
may be possible through the integration of patient,
illness and medicine information, and through the
development of an alert hierarchy to generate at most
one clinically relevant alert per prescription. Ideally,
alerts will only be displayed when there is a true risk of
harm, but will always be displayed when such risks exist,
to the extent that it is desirable or necessary for the
user. Given that no practical system can achieve 100%
specificity and 100% sensitivity, the best balance needs
to be determined. We believe that specificity can be
increased without sacrificing sensitivity through the in-
tegration and linkage of solid knowledge bases and pa-
tient parameters, using well-tailored algorithms. Future
collaboration with researchers and practitioners from
other countries, such as the United States, where the
use of CDS systems is prominent, is also important.
However, this does mean that, even if conclusions can
be made about optimal alert generation, it may not be
possible to implement universal change within every
system in every hospital.
Strengths and limitations of the approach
This workshop successfully facilitated collaboration and
communication between researchers, which allowed for
the further refinement of research priorities and the
generation of future research ideas. Most discussion on
CDS has come from the United States [7,43]; here we
have identified and refined the knowledge gaps, particu-
larly relevant to the European market. Workshop partic-
ipants were experts in the use of CDS, with a wide
breadth of knowledge of and experience in using a var-
iety of locally-developed and commercial prescribing
systems. However, as a limitation, the majority of partici-
pants were academic researchers and we did not consult
other potentially relevant groups such as CDS vendors.
Time constraints also meant that not every knowledge
gap could be expanded upon during the workshop. Fur-
thermore, despite a varied representation of participants
from across Europe, this paper cannot, unfortunately,
provide a pan-European perspective on alerts in CDS.
Conclusions
The use of CDS systems within CPOE is increasing rap-
idly and is becoming an essential component of patient
care in many countries. Previous research has indicated
the need to eliminate alert fatigue, but this has yet to be
achieved in practice. Research should be undertaken to
determine whether the use of CDS alerts really improves
patient outcomes, using appropriate methodologies and
appropriate outcome measures. Strategies must be devel-
oped to reduce the burden of CDS alerts without com-
promising patient safety.
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